SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-025998
Filing Date
2020-04-28
Accepted
2020-04-28 17:42:53
Documents
1
Period of Report
2020-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 19513
  Complete submission text file 0001209191-20-025998.txt   22036
Mailing Address C/O COLUMN GROUP LP 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
GOEDDEL DAVID V (Reporting) CIK: 0001182464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 20826369

Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Reporting) CIK: 0001600420 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 20826367

Mailing Address 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158 415-865-2050
Column Group II GP, LP (Reporting) CIK: 0001645333 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 20826368

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences